Nichols J, Schiffer C, Royer Jr W
J Biol Chem. 2021; 296:100351.
PMID: 33524397
PMC: 7949142.
DOI: 10.1016/j.jbc.2021.100351.
Jecrois A, Dcona M, Deng X, Bandyopadhyay D, Grossman S, Schiffer C
Structure. 2020; 29(4):310-319.e5.
PMID: 33264605
PMC: 9159756.
DOI: 10.1016/j.str.2020.11.008.
Parhad S, Yu T, Zhang G, Rice N, Weng Z, Theurkauf W
Cell Rep. 2020; 30(8):2672-2685.e5.
PMID: 32101744
PMC: 7061269.
DOI: 10.1016/j.celrep.2020.01.109.
Dickherber M, Garnett-Benson C
Virol J. 2019; 16(1):161.
PMID: 31864392
PMC: 6925507.
DOI: 10.1186/s12985-019-1265-y.
Dcona M, Damle P, Zarate-Perez F, Morris B, Nawaz Z, Dennis M
Mol Pharmacol. 2019; 96(1):99-108.
PMID: 31036695
PMC: 6560337.
DOI: 10.1124/mol.118.114363.
An intestinal stem cell niche in mutated neoplasia targetable by CtBP inhibition.
Chawla A, Cororaton A, Idowu M, Damle P, Szomju B, Ellis K
Oncotarget. 2018; 9(65):32408-32418.
PMID: 30197752
PMC: 6126694.
DOI: 10.18632/oncotarget.25784.
Assembly of human C-terminal binding protein (CtBP) into tetramers.
Bellesis A, Jecrois A, Hayes J, Schiffer C, Royer Jr W
J Biol Chem. 2018; 293(23):9101-9112.
PMID: 29700119
PMC: 5995525.
DOI: 10.1074/jbc.RA118.002514.
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
Korwar S, Morris B, Parikh H, Coover R, Doughty T, Love I
Bioorg Med Chem. 2016; 24(12):2707-15.
PMID: 27156192
PMC: 4993153.
DOI: 10.1016/j.bmc.2016.04.037.
Structure-guided design of a high affinity inhibitor to human CtBP.
Hilbert B, Morris B, Ellis K, Paulsen J, Schiffer C, Grossman S
ACS Chem Biol. 2015; 10(4):1118-27.
PMID: 25636004
PMC: 4844192.
DOI: 10.1021/cb500820b.
Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
Hilbert B, Grossman S, Schiffer C, Royer Jr W
FEBS Lett. 2014; 588(9):1743-8.
PMID: 24657618
PMC: 4072453.
DOI: 10.1016/j.febslet.2014.03.026.
Nicotinamide adenine dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a switching tryptophan.
Madison D, Wirz J, Siess D, Lundblad J
J Biol Chem. 2013; 288(39):27836-48.
PMID: 23940047
PMC: 3784699.
DOI: 10.1074/jbc.M113.493569.
C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis.
Stankiewicz T, Schroeder E, Kelsey N, Bouchard R, Linseman D
Mol Cell Neurosci. 2013; 56:322-332.
PMID: 23859824
PMC: 3791214.
DOI: 10.1016/j.mcn.2013.07.004.
C-terminal binding protein (CtBP) activates the expression of E-box clock genes with CLOCK/CYCLE in Drosophila.
Itoh T, Matsumoto A, Tanimura T
PLoS One. 2013; 8(4):e63113.
PMID: 23646183
PMC: 3640014.
DOI: 10.1371/journal.pone.0063113.
CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1.
Paliwal S, Ho N, Parker D, Grossman S
Genes Cancer. 2012; 3(7-8):481-90.
PMID: 23264848
PMC: 3527986.
DOI: 10.1177/1947601912463695.
Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription.
Rajendran R, Garva R, Krstic-Demonacos M, Demonacos C
J Biomed Biotechnol. 2011; 2011:368276.
PMID: 21912480
PMC: 3168296.
DOI: 10.1155/2011/368276.
The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets.
Bhambhani C, Chang J, Akey D, Cadigan K
EMBO J. 2011; 30(10):2031-43.
PMID: 21468031
PMC: 3098475.
DOI: 10.1038/emboj.2011.100.
Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development.
Zhang Y, Arnosti D
Mol Cell Biol. 2010; 31(2):375-84.
PMID: 21078873
PMC: 3019976.
DOI: 10.1128/MCB.00772-10.
Therapeutic targeting of C-terminal binding protein in human cancer.
Straza M, Paliwal S, Kovi R, Rajeshkumar B, Trenh P, Parker D
Cell Cycle. 2010; 9(18):3740-50.
PMID: 20930544
PMC: 3047800.
DOI: 10.4161/cc.9.18.12936.
Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.
Winklmeier A, Poser I, Hoek K, Bosserhoff A
BMC Cancer. 2009; 9:52.
PMID: 19216735
PMC: 2650708.
DOI: 10.1186/1471-2407-9-52.